US Stock MarketDetailed Quotes
ERNA Eterna Therapeutics
- 1.070
- +0.030+2.88%
Close Nov 4 16:00 ET
- 1.120
- +0.050+4.66%
Post 20:01 ET
5.79MMarket Cap-241P/E (TTM)
1.120High1.035Low10.27KVolume1.070Open1.040Pre Close11.20KTurnover0.31%Turnover RatioLossP/E (Static)5.41MShares2.62552wk High-0.68P/B3.51MFloat Cap0.83552wk Low--Dividend TTM3.28MShs Float1613.400Historical High--Div YieldTTM8.17%Amplitude0.835Historical Low1.089Avg Price1Lot Size
About Eterna Therapeutics Company
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.
Company Profile
SymbolERNA
Company NameEterna Therapeutics
Listing DateOct 1, 1984
Founded1984
CEOMr. Sanjeev Luther
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address1035 Cambridge Street,Suite 18A
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-212-582-1199
Websitehttp://eternatx.com
Company Executives
- Name
- Position
- Salary
- Sanjeev Luther
- Director, President and Chief Executive Officer
- --
- Sandra M. Gurrola
- Principal Financial Officer, Principal Accounting Officer and Senior Vice President, Finance
- 305.88K
- Dr. James A. Bristol, PhD
- Chairman of the Board
- --
- Dorothy J. Clarke
- Director and General Counsel
- --
- Peter Cicala
- Independent Director
- --
- William A. Wexler
- Independent Director
- 112.29K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data